Prescription Opioid Threat in Pennsylvania, 2020
September 03, 2020
The PDIP strives to maintain situational awareness of the threat posed by prescription opioids in Pennsylvania, and to share these analyses with stakeholders in federal, state, and municipal governments. In 2013, the PDIP published a Pharmaceutical Threat Assessment for Pennsylvania that found prescription opioid availability and abuse at epidemic levels. In 2016 and 2019, the PDIP published updated assessments detailing prescription opioid availability and abuse trends; this 2020 assessment builds on the previous analyses.